Drug Utilization Review Board
Meeting Agenda
Thursday, March 12, 2025
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/qbv-rjpz-fst
Or dial: (US) +1 314-474-3014 PIN: 334 496 072#
Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov at least 1 week prior to the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Sharon Weinstein, MD
a) Welcome and Introductions
b) Review and Approval of Minutes
c) Housekeeping - Luis Moreno, PharmD
2) Prior Authorization Updates - Luis Moreno, PharmD
3) P&T Committee Update - Ngan Huynh, PharmD
4) Review Topic
a) GLP-1 Receptor Agonists for the Treatment of Obesity: Long-Term Benefits & Discontinuation After Ongoing Treatment - Monet Luloh, PharmD
i) Committee Discussion/Questions
5) Public Comment
6) Review New Prior Authorization Criteria
a) Kisunla (donanemab-azbt) - Iris Wan, PharmD
i) Committee Discussion/Questions
ii) Committee Action
b) Pompe Disease - Luis Moreno, PharmD
i) Committee Discussion/Questions
ii) Committee Action
7) Next Meeting
a) Date: April 9, 2026
b) Topic: Understanding the Economic Value of FDA-Approved GLP-1 Receptor Agonists for Weight Loss/Maintenance.
8) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/qbv-rjpz-fst
Or dial: (US) +1 314-474-3014 PIN: 334 496 072#